UDICAD-300 contains Ursodeoxycholic Acid 300 mg, designed for selected hepatobiliary and cholestatic conditions requiring ursodeoxycholic-acid therapy. A strong PCD Pharma Hepatoprotective range product.
Selected cholestatic liver disorders and appropriate gallstone-related conditions.
Yes, treatment is individualized.
Take according to the physician’s prescribed dose and duration. Regular monitoring may be necessary for liver function and treatment response.
Diarrhea, abdominal discomfort, nausea, constipation and headache may occur.
UDICAD-300: Ursodeoxycholic Acid improves bile flow and alters bile composition, reducing cholesterol saturation of bile and supporting selected hepatobiliary conditions.
